Home/Filings/4/0001485003-17-000027
4//SEC Filing

Eleven Biotherapeutics, Inc. 4

Accession 0001485003-17-000027

$CARMCIK 0001485003operating

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:13 PM ET

Size

5.3 KB

Accession

0001485003-17-000027

Insider Transaction Report

Form 4
Period: 2017-04-03
MCCABE JOHN J
Senior Vice President, Finance
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-04-03+14,07714,077 total
    Exercise: $2.28Exp: 2027-04-02Common Stock (14,077 underlying)
Footnotes (1)
  • [F1]50% of the shares subject to such option shall vest on grant date with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date.

Issuer

Eleven Biotherapeutics, Inc.

CIK 0001485003

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001485003

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:13 PM ET
Size
5.3 KB